BioCentury | Dec 31, 2020
Deals

Dec. 30 Quick Takes: COVAXX-Aurobindo and Moderna-Recipharm in COVID deals; plus United-Y-mAbs, Zai-Cullinan and Incyte-Cellenkos

...plus high single-digit to low-teen tiered royalties.Incyte, Cellenkos...
...to test Jakafi-Treg comboIncyte Corp. (NASDAQ:INCY) and Cellenkos Inc....
...Treg cells, for hematology indications; if exercised, Cellenkos...
BioCentury | Jan 9, 2019
Company News

Management tracks: Tak joins Flagship, Evercore taps Mehrotra

...Inc. (NASDAQ:ARAY) (see "Energy Firm Spins Out Biotech with $40M Series A" ). Immunotherapy play Cellenkos Inc....
BioCentury | Sep 26, 2016
Financial News

Cellenkos completes venture financing

Cellenkos Inc. , Houston, Texas Business: Gene/Cell therapy, Autoimmune Date completed: 2016-09-18 Type: Venture financing Raised: $10 million Investors: Golden Meditech Holdings Ltd.; and an undisclosed investor WIR Staff...
BioCentury | Sep 20, 2016
Financial News

Cellenkos raises $10M venture round

...of Texas MD Anderson Cancer Center and Golden Meditech Ltd. (HKSE:00801; Taiwan:910801) launched immunotherapy newco Cellenkos Inc....
...with $10 million in a venture round. Golden Meditech and an undisclosed strategic investor participated. Cellenkos...
...If they exercise the warrants, the two investors will jointly hold a 51% stake in Cellenkos...
Items per page:
1 - 4 of 4
BioCentury | Dec 31, 2020
Deals

Dec. 30 Quick Takes: COVAXX-Aurobindo and Moderna-Recipharm in COVID deals; plus United-Y-mAbs, Zai-Cullinan and Incyte-Cellenkos

...plus high single-digit to low-teen tiered royalties.Incyte, Cellenkos...
...to test Jakafi-Treg comboIncyte Corp. (NASDAQ:INCY) and Cellenkos Inc....
...Treg cells, for hematology indications; if exercised, Cellenkos...
BioCentury | Jan 9, 2019
Company News

Management tracks: Tak joins Flagship, Evercore taps Mehrotra

...Inc. (NASDAQ:ARAY) (see "Energy Firm Spins Out Biotech with $40M Series A" ). Immunotherapy play Cellenkos Inc....
BioCentury | Sep 26, 2016
Financial News

Cellenkos completes venture financing

Cellenkos Inc. , Houston, Texas Business: Gene/Cell therapy, Autoimmune Date completed: 2016-09-18 Type: Venture financing Raised: $10 million Investors: Golden Meditech Holdings Ltd.; and an undisclosed investor WIR Staff...
BioCentury | Sep 20, 2016
Financial News

Cellenkos raises $10M venture round

...of Texas MD Anderson Cancer Center and Golden Meditech Ltd. (HKSE:00801; Taiwan:910801) launched immunotherapy newco Cellenkos Inc....
...with $10 million in a venture round. Golden Meditech and an undisclosed strategic investor participated. Cellenkos...
...If they exercise the warrants, the two investors will jointly hold a 51% stake in Cellenkos...
Items per page:
1 - 4 of 4